Resonance Specialties today said its manufacturing facility at Mandideep has been inspected by US health regulator USFDA.
One of the company's manufacturing sites -- Vista Organics Pvt, Mandideep -- has been recently inspected by the United States Food and Drug Administration (USFDA), Resonance Specialties said in a BSE filing.
"No 483 observations have been issued and Establishment Inspection Report (EIR) is awaited," it added.
EIR is given after the successful completion of the inspection by USFDA.
The stock of Resonance Specialties today closed 4.93 per cent lower at Rs 38.60 on BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)